Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Burkitt Lymphoma 39Lymphoma, Follicular 37Leukemia, Lymphocytic, Chronic, B-Cell 37Lymphoma, Mantle-Cell 36Lymphoma, B-Cell, Marginal Zone 35Multiple Myeloma 34Lymphoma, Non-Hodgkin 33Lymphoma, Large-Cell, Immunoblastic 33Leukemia, Myeloid, Acute 33Hodgkin Disease 33Lymphoma, Large B-Cell, Diffuse 32Recurrence 30Myelodysplastic Syndromes 29Leukemia 28Myeloproliferative Disorders 27Leukemia, Myeloid, Chronic-Phase 27Congenital Abnormalities 27Lymphoma 26Leukemia, Myeloid, Accelerated Phase 24Lymphoma, Large-Cell, Anaplastic 21Waldenstrom Macroglobulinemia 20Sezary Syndrome 20Mycosis Fungoides 20Leukemia, Myelomonocytic, Chronic 20Lymphoma, T-Cell, Cutaneous 19Leukemia, Myelomonocytic, Juvenile 19Primary Myelofibrosis 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

Cyclophosphamide 13fludarabine 7Trabectedin 4Radiation Dose Hypofractionation 3seclidemstat 2pembrolizumab 2Topotecan 2Interferon-gamma 2selinexor 1ribociclib 1pazopanib 1palbociclib 1mirdametinib 1itacitinib 1interferon gamma-1b 1fludarabine phosphate 1cytochrome C synthetase 1brostallicin 1baricitinib 1atezolizumab 1aldesleukin 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Sirolimus 1Radiotherapy 1Radiation 1Proton Therapy 1Pioglitazone 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma, Myxoid × fludarabine phosphate × Sarcoma × Clear all
NCT06083883 2026-04-16

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡